Neurology 63(9):17051707 Akanji MA et al (2021) Redox homeostasis and prospects for therapeutic targeting in neurodegenerative disorders
Most incretin weight-loss therapies are injected subcutaneously, but oral semaglutide is already licensed in the UK for T2DM as Rybelsus, while its manufacturer Novo Nordisk has published positive phase III results (OASIS-4, NCT05564117) for its 25mg semaglutide pill for weight loss 6
largely a primary prevention cohort), showed a non-significant reduction in MACE versus placebo, but did find a significant reduction in the composite co-primary outcome of CV death and hospitalisation for HF (Viviott et al, 2019)
Finally, self-diagnosis is not a substitute for professional assessment
CXCL5, a secreted chemokine that recruits neutrophils, has been linked to a reduced TEER and ZO-1 expression mediated via activation of p38 MAPkinase pathways in primary BECs (Yu et al., 2021)
Hyperpigmentation is a medical condition, and every treatment described here is prescribed and administered by a licensed provider after an in person evaluation